The second life of salinomycin: Chemo- and regioselective modifications of salinomycin and their influence on the anti-cancer and anti-microbial activity

2016/23/D/ST5/00242

Keywords

Descriptors

  • ST5_16: Chemia biologiczna
  • ST5_23: Chemia organiczna

Panel

ST5 – Materials: materials synthesis, structure-properties relations, advanced and functional materials with designed properties, (macro)molecular architecture, material engineering

Host institution

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

Voivodeship: wielkopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Michał Piotr Antoszczak

Number of co-investigators in the project: 5

Call

SONATA 12 – announced on 2016-09-15

Amount awarded
726 338 PLN
Project start date
2017-07-11
Project end date
2020-07-10
Project duration
36 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Kolumny do HPLC (analityczne i preparatywne). Cost: 10 000 PLN
  2. Kolumny do HPLC z wypełnieniem chiralnym. Cost: 10 000 PLN
  3. Komputer typu notebook. Cost: 6 000 PLN
  4. Laboratoryjna pompa strzykawkowa. Cost: 15 000 PLN
  5. Modułowy, wielostanowiskowy system do syntezy równoległej. Cost: 50 000 PLN
  6. System do chromatografii typu FLASH i preparatywnej z detektorami UV oraz ELSD. Cost: 300 000 PLN
  7. Waga laboratoryjna. Cost: 8 000 PLN
  8. Łaźnia (myjka) ultradźwiękowa. Cost: 9 000 PLN

Information in the final report

Publication in academic press/journals (14)

  1. Synteza i aktywność biologiczna pochodnych salinomycyny

    Authors:
    M. Antoszczak*, A. Huczyński, B. Brzezinski
    Academic press:
    Wiadomości Chemiczne (year: 2017, volume: 71, pages: 629-661), Publisher: Polskie Towarzystwo Chemiczne
    Status:
    Published
  2. Synthesis and anticancer activity of dimeric polyether ionophores

    Authors:
    M. Sulik, E. Maj, J. Wietrzyk, A. Huczyński, M. Antoszczak*
    Academic press:
    Biomolecules (year: 2020, volume: 10, pages: 1039), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/biom10071039 – link to the publication
  3. Synthesis and anticancer activity of tertiary amides of salinomycin and their C20-oxo analogues

    Authors:
    D. Czerwonka, A. Urbaniak, S. Sobczak, S. Piña-Oviedo, T.C. Chambers, M. Antoszczak*, A. Huczyński
    Academic press:
    ChemMedChem (year: 2020, volume: 15, pages: 236-246), Publisher: Wiley
    Status:
    Published
    DOI:
    10.1002/cmdc.201900593 – link to the publication
  4. Salinomycin and its derivatives – A new class of multiple-targeted magic bullets

    Authors:
    M. Antoszczak, A. Huczyński
    Academic press:
    European Journal of Medicinal Chemistry (year: 2019, volume: 176, pages: 208-227), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2019.05.031 – link to the publication
  5. Overcoming resistance to platinum-based drugs in ovarian cancer by salinomycin and its derivatives – An in vitro study

    Authors:
    M. Michalak, M.S. Lach, M. Antoszczak, A. Huczyński, W.M. Suchorska
    Academic press:
    Molecules (year: 2020, volume: 25, pages: 537), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules25030537 – link to the publication
  6. Antibacterial activity of singly and doubly modified salinomycin derivatives

    Authors:
    M. Sulik, K. Stępień, J. Stefańska, A. Huczyński, M. Antoszczak*
    Academic press:
    Bioorganic & Medicinal Chemistry Letters (year: 2020, volume: 30, pages: 127062), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bmcl.2020.127062 – link to the publication
  7. Anti-trypanosomal activity of doubly modified salinomycin derivatives

    Authors:
    M. Antoszczak*, D. Steverding, M. Sulik, J. Janczak, A. Huczyński
    Academic press:
    European Journal of Medicinal Chemistry (year: 2019, volume: 173, pages: 90-98), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2019.03.061 – link to the publication
  8. Biological activity of doubly modified salinomycin analogs - Evaluation in vitro and ex vivo

    Authors:
    M. Antoszczak*, A. Urbaniak, M. Delgado, E. Maj, B. Borgstrom, J. Wietrzyk, A. Huczyński, Y. Yuan, T.C. Chambers, D. Strand
    Academic press:
    European Journal of Medicinal Chemistry (year: 2018, volume: 156, pages: 510-523), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2018.07.021 – link to the publication
  9. Salinomycin derivatives exhibit activity against primary acute lymphoblastic leukemia (ALL) cells in vitro

    Authors:
    A. Urbaniak, M. Delgado, M. Antoszczak, A. Huczyński, T.C. Chambers
    Academic press:
    Biomedicine & Pharmacotherapy (year: 2018, volume: 99, pages: 384-390), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.biopha.2018.01.081 – link to the publication
  10. Biokoniugaty antybiotyków jonoforowych - Cele, strategie syntezy i właściwości

    Authors:
    M. Antoszczak*, M. Kordylas, A. Huczyński
    Academic press:
    Wiadomości Chemiczne (year: 2018, volume: 72, pages: 46050), Publisher: Polskie Towarzystwo Chemiczne
    Status:
    Published
  11. A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents

    Authors:
    M. Antoszczak*
    Academic press:
    European Journal of Medicinal Chemistry (year: 2019, volume: 166, pages: 48-64), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2019.01.034 – link to the publication
  12. Anti-parasitic activity of polyether ionophores

    Authors:
    M. Antoszczak, D. Steverding, A. Huczyński
    Academic press:
    European Journal of Medicinal Chemistry (year: 2019, volume: 166, pages: 32-47), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2019.01.035 – link to the publication
  13. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent

    Authors:
    M. Antoszczak*
    Academic press:
    European Journal of Medicinal Chemistry (year: 2019, volume: 164, pages: 366-377), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2018.12.057 – link to the publication
  14. Singly and doubly modified analogues of C20-epi-salinomycin: A new group of antiparasitic agents against Trypanosoma brucei

    Authors:
    D. Czerwonka, Y. Barcelos, D. Steverding, A. Cioch, A. Huczyński, M. Antoszczak*
    Status:
    Accepted for publication

Articles in post-conference publications (1)

  1. Double modification of polyether ionophores: Synthesis and biological activity of novel salinomycin derivatives

    Authors:
    M. Antoszczak*, D. Czerwonka, A. Urbaniak, S. Sobczak, T.C. Chambers, A. Huczyński
    Conference:
    2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery (year: 2019, pages: 20), Publisher: MDPI
    Date:
    conference 43600
    Status:
    Published

Book publications / chapters in book publications (1)

  1. Zastosowanie antybiotyków jonoforowych oraz ich pochodnych w walce ze śpiączką afrykańską

    Authors:
    M. Sulik, M. Antoszczak*, A. Huczyński
    Book:
    Na pograniczu chemii i biologii (year: 2019, volume: XXXIX, pages: 46287), Publisher: Wydawnictwo Naukowe UAM
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski